[IOICORP] QoQ TTM Result on 31-Mar-2011 [#3]

Announcement Date
16-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2011
Quarter
31-Mar-2011 [#3]
Profit Trend
QoQ- 5.09%
YoY- 12.47%
Quarter Report
View:
Show?
TTM Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 16,978,004 16,782,591 16,154,251 14,889,944 13,697,012 12,786,762 12,542,962 22.29%
PBT 2,703,442 2,625,966 2,863,612 2,749,942 2,678,346 2,587,263 2,550,633 3.94%
Tax -614,349 -575,242 -573,099 -472,232 -510,922 -497,823 -485,517 16.93%
NP 2,089,093 2,050,724 2,290,513 2,277,710 2,167,424 2,089,440 2,065,116 0.77%
-
NP to SH 2,040,333 1,982,871 2,222,899 2,222,126 2,114,434 2,055,407 2,035,661 0.15%
-
Tax Rate 22.72% 21.91% 20.01% 17.17% 19.08% 19.24% 19.04% -
Total Cost 14,888,911 14,731,867 13,863,738 12,612,234 11,529,588 10,697,322 10,477,846 26.31%
-
Net Worth 12,144,648 11,620,739 11,995,655 11,340,260 11,043,089 10,523,830 10,787,801 8.19%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 1,027,132 1,087,994 1,087,994 1,148,994 1,148,994 1,057,070 1,057,070 -1.89%
Div Payout % 50.34% 54.87% 48.94% 51.71% 54.34% 51.43% 51.93% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 12,144,648 11,620,739 11,995,655 11,340,260 11,043,089 10,523,830 10,787,801 8.19%
NOSH 6,425,739 6,420,298 6,414,789 6,406,926 6,383,288 6,378,079 6,383,314 0.44%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 12.30% 12.22% 14.18% 15.30% 15.82% 16.34% 16.46% -
ROE 16.80% 17.06% 18.53% 19.60% 19.15% 19.53% 18.87% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 264.22 261.40 251.83 232.40 214.58 200.48 196.50 21.75%
EPS 31.75 30.88 34.65 34.68 33.12 32.23 31.89 -0.29%
DPS 16.00 17.00 17.00 18.00 18.00 16.57 16.56 -2.26%
NAPS 1.89 1.81 1.87 1.77 1.73 1.65 1.69 7.71%
Adjusted Per Share Value based on latest NOSH - 6,406,926
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 273.77 270.62 260.49 240.10 220.86 206.19 202.25 22.29%
EPS 32.90 31.97 35.84 35.83 34.10 33.14 32.82 0.16%
DPS 16.56 17.54 17.54 18.53 18.53 17.05 17.05 -1.92%
NAPS 1.9583 1.8738 1.9343 1.8286 1.7807 1.697 1.7395 8.19%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 5.38 4.65 5.30 5.76 5.81 5.47 5.01 -
P/RPS 2.04 1.78 2.10 2.48 2.71 2.73 2.55 -13.78%
P/EPS 16.94 15.06 15.29 16.61 17.54 16.97 15.71 5.13%
EY 5.90 6.64 6.54 6.02 5.70 5.89 6.37 -4.96%
DY 2.97 3.66 3.21 3.13 3.10 3.03 3.31 -6.95%
P/NAPS 2.85 2.57 2.83 3.25 3.36 3.32 2.96 -2.48%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 23/02/12 18/11/11 24/08/11 16/05/11 16/02/11 18/11/10 24/08/10 -
Price 5.33 5.06 4.67 5.19 5.71 5.90 5.25 -
P/RPS 2.02 1.94 1.85 2.23 2.66 2.94 2.67 -16.92%
P/EPS 16.79 16.38 13.48 14.96 17.24 18.31 16.46 1.32%
EY 5.96 6.10 7.42 6.68 5.80 5.46 6.07 -1.20%
DY 3.00 3.36 3.64 3.47 3.15 2.81 3.15 -3.19%
P/NAPS 2.82 2.80 2.50 2.93 3.30 3.58 3.11 -6.30%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment